Hypovitaminosis D osteopathy: Is it mediated through PTH, lean mass, or is it a direct effect?

Bone

Volumn 39, Issue 2, 2006, Pages 268-275

  Arabi, Asma ^a   Baddoura, Rafic ^b   Awada, Hassane ^b   Salamoun, Mariana ^a   Ayoub, Ghazi ^b   El Hajj Fuleihan, Ghada ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

BMD; Elderly; Lean mass; PTH; Vitamin D osteopathy

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; BONE MASS; CALCIUM BLOOD LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENDER; HUMAN; HYPERPARATHYROIDISM; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; OSTEOPATHIC MEDICINE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; SPINE; VITAMIN DEFICIENCY;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BODY COMPOSITION; BONE DENSITY; CALCIUM; DENSITOMETRY, X-RAY; FEMALE; FEMUR; HUMANS; LEBANON; LINEAR MODELS; MALE; PARATHYROID HORMONE; RETROSPECTIVE STUDIES; RICKETS; SEX FACTORS; THINNESS; URBAN POPULATION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 33744931640     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.01.140     Document Type: Article

References (37)

1. Heaney R.P. Long-latency deficiency disease: insights from calcium and vitaminD. Am. J. Clin. Nutr. 78 (2003) 912-919
2. Bhattoa H.P., Bettembuk P., Ganacharya S., and Balogh A. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Osteoporos. Int. 15 (2004) 447-451
3. Bettica P., Bevilacqua M., Vago T., and Norbiato G. High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening. Osteoporos. Int. 9 (1999) 226-229
4. Isaia G., Giorgino R., Rini G.B., Bevilacqua M., Maugeri D., and Adami S. Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos. Int. 14 (2003) 577-582
5. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 7 (1997) 439-443
6. Bischoff-Ferrari H.A., Dietrich T., Orav J., and Dawson-Hughes B. Positive association between 25-hydroxyvitamin D levels and bone mineral density: a population-based study of younger and older adults. Am. J. Med. 116 (2004) 634-639
7. Collins D., Jasani C., Fogelman I., and Swaminathan R. Vitamin D and bone mineral density. Osteoporos. Int. 8 (1998) 110-114
8. Fradinger E., and Zanchetta J. Vitamin D and bone mineral density in ambulatory women living in Buenos Aires, Argentina. Osteoporos. Int. 12 (2001) 24-27
9. Parfitt A.M., Gallagher J.C., Heaney R.P., Johnston C.C., Neer R., and Whedon G.D. Vitamin D and bone health in the elderly. Am. J. Clin. Nutr. 36 (1982) 1014-1031
10. Boonen S., Vanderschueren D., Cheng X.G., Verbeke G., Dequeker J., Geusens P., et al. Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption. J. Bone Miner. Res. 12 (1997) 2119-2126
11. LeBoff M.S., Kohlmeier L., Hurwitz S., Franklin J., Wright J., and Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 281 (1999) 1505-1511
12. Flicker L., Mead K., MacInnis R.J., Nowson C., Scherer S., Stein M.S., et al. Serum vitamin D and falls in older women in residential care in Australia. J. Am. Geriatr. Soc. 51 (2003) 1533-1538
13. Dukas L., Bischoff H.A., Lindpaintner L.S., Schacht E., Birkner-Binder D., Damm T.N., et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J. Am. Geriatr. Soc. 52 (2004) 230-236
14. Chapuy M.C., Pamphile R., Paris E., Kempf C., Schlichting M., Arnaud S., et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos. Int. 13 (2002) 257-264
15. Ooms M.E., Roos J.C., Bezemer P.D., van der Vijgh W.J., Bouter L.M., and Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J. Clin. Endocrinol. Metab. 80 (1995) 1052-1058
16. Dawson-Hughes B., Harris S.S., Krall E.A., and Dallal G.E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N. Engl. J. Med. 337 (1997) 670-676
17. Bischoff H.A., Stahelin H.B., Dick W., Akos R., Knecht M., Salis C., et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J. Bone Miner. Res. 18 (2003) 343-351
18. Bischoff-Ferrari H.A., Dawson-Hughes B., Willett W.C., Staehelin H.B., Bazemore M.G., Zee R.Y., et al. Effect of Vitamin D on falls: a meta-analysis. JAMA 291 (2004) 1999-2006
19. Chen Z., Lohman T.G., Stini W.A., Ritenbaugh C., and Aickin M. Fat or lean tissue mass: which one is the major determinant of bone mineral mass in healthy postmenopausal women?. J. Bone Miner. Res. 12 (1997) 144-151
20. Khosla S., Atkinson E.J., Riggs B.L., and Melton III L.J. Relationship between body composition and bone mass in women. J. Bone Miner. Res. 11 (1996) 857-863
21. Visser M., Deeg D.J., and Lips P. Longitudinal Aging Study Amsterdam low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J. Clin. Endocrinol. Metab. 88 (2003) 5766-5772
22. Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal.
23. Mezquita-Raya P., Munoz-Torres M., Luna J.D., Luna V., Lopez-Rodriguez F., Torres-Vela E., et al. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J. Bone Miner. Res. 16 (2001) 1408-1415
24. Baron R.M., and Kenny D.A. The moderator variable distinction in social psychological research: conceptual strategic and statistical considerations. J. Pers. Soc. Psychol. 51 (1986) 1173-1182
25. Genant H.K., Grampp S., Gluer C.C., Faulkner K.G., Jergas M., Engelke K., et al. Universal standardization for dual energy X-ray absorptiometry: patient and phantom cross-calibration result. J. Bone Miner. Res. 10 (1994) 1004-1014
26. Sigurdsson G., Franzson L., Steingrimsdottir L., and Sigvaldason H. The association between parathyroid hormone, vitamin D and bone mineral density in 70-year-old Icelandic women. Osteoporos. Int. 11 (2000) 1031-1035
27. Pfeifer M., Begerow B., and Minne H.W. Vitamin D and muscle function. Osteoporos. Int. 13 (2002) 187-194
28. Bischoff H., Stahelin H., Ursheler N., Ehrsam R., Vonthein R., Perring-Chiello P., et al. Muscle strength in the elderly: Its relation to vitamin D metabolites. Arch. Phys. Med. Rehabil. 80 (1999) 54-58
29. Meyer H.E., Falch J.A., Sogaard A.J., and Haug E. Vitamin D deficiency and secondary hyperparathyroidism and the association with bone mineral density in persons with Pakistani and Norwegian background living in Oslo, Norway, The Oslo Health Study. Bone 35 (2004) 412-417
30. Pluijm S.M.F., Visser M., Smit J.H., Popp-Snijders C., Roos J.C., and Lips P. determinants of bone mineral density in older men and women: body composition as mediator. J. Bone Miner. Res. 16 (2001) 2142-2151
31. Arabi A., Tamim H., Nabulsi M., Maalouf J., Khalifé H., Choucair M., et al. Sex differences in the effect of body-composition variables on bone mass in healthy children and adolescents. Am. J. Clin. Nutr. 80 (2004) 1428-1435
32. Duque G., Abdaimi K., Henderson J., Lomri A., and Kremer R. vitamin D inhibits Fas ligand-induced apoptosis in human osteoblasts by regulating components of both the mitochondrial and Fas-related pathways. Bone 35 (2004) 57-64
33. O'Brien C., Gubrij I., Lin S.C., Saylors R., and Manolagas S. STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kB ligand and stimulation of osteoclastogenesis by gp 130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone. J. Biol. Chem. 274 (1999) 19301-19308
34. Fleet J.C. Genomic and proteomic approaches for probing the role of vitamin D on health. Am. J. Clin. Nutr. 80 Suppl. 6 (2004) S1730-S1734
35. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., Shaw A.C., Deraska D.J., Kitch B.T., et al. Hypovitaminosis D in medical inpatients. N. Engl. J. Med. 338 (1998) 777-783
36. Gloth III F.M., Gundberg C.M., Hollis B.W., Haddad Jr. J.G., and Tobin J.D. Vitamin D deficiency in homebound elderly persons. JAMA 274 (1995) 1683-1686
37. Hollis B. Comparison of commercially available I-based RIA methods for the determination of circulating 25-D. Hydroxyvitamin. Clin. Chem. 46 (2000) 1657-1661